UAE – When will the Pfizer vaccine be ready for use?

(MENAFN – Al-Bayan) Source: Date: November 14, 2020 The announcement by the two companies, “Pfizer” and “Biontech”, that the upcoming Corona vaccine was reached, raised questions about the possible date for the readiness of this vaccine, especially since the start of vaccinating people will mark the return of life to normal, albeit gradually.

According to “CNN”, according to officials and health experts, the vaccine announced by “Pfizer” and was very welcomed, will not be ready until the second half of next December.
The vaccine, which was developed in a record period of time, requires this period, because it is required to obtain approval from one of the most prominent health and scientific institutions in the United States.

Experts say that the Pfizer / Bionic vaccine will not obtain approval from the US Food and Drug Administration until the second half of December, meaning that it still takes several weeks. According to Sky News Arabia.
Larry Curry, an academic at the University of Washington and a prominent member of the clinical trials of the Coronavirus vaccine, says that the US Food and Drug Administration will take approximately 10 days for it to review clinical trial data on the vaccine.

The American scientist added that the prestigious US agency will also look into the standards for producing this vaccine, in order to make sure that they comply with the required manufacturing specifications.

The researcher said, “I am not sure how long this will take, but it may be in two weeks. This is reasonable.”

The Food and Drug Administration undertook to seek the assistance of the Advisory Committee on Vaccines and Related Biological Products in the United States, known as “VRBPAC”.

In the same direction, the researcher and member of this committee, Paul Offit, is likely to have the vaccine against the Corona epidemic ready next December.

The American academic indicated that the opinion of this advisory committee may be requested as early as next December.

But setting a date for vaccine readiness is not an easy matter, because several companies started producing the vaccine before it received approval, in order to gain time, especially since this approval for use appears to be almost guaranteed.

On Monday, the companies “Pfizer” clarified that what they announced, finally, is included in the initial data only, but the latter cannot be sent to the Food and Drug Administration in order to obtain approval for emergency use.

And the US Food and Drug Administration requires companies to wait two full weeks when half of the volunteers receive a second dose of the vaccine.

After waiting two weeks, the company can submit a formal application for the emergency use license.

Follow the world news from the statement via Google News

MENAFN14112020000110011019ID1101125958